Skip to main content

Year: 2025

Actelis Networks Announces Pricing of $5 Million Public Offering

SUNNYVALE, Calif, Dec. 17, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced the pricing of a public offering of an aggregate of 6,250,000 shares of the Company’s common stock (or pre-funded warrants in lieu thereof), together with warrants to purchase up to 6,250,000 shares of common stock at a combined public offering price of $0.80 per share (or pre-funded warrant in lieu thereof) and associated warrant. The warrants will have an exercise price of $0.80 per share, will be exercisable upon issuance and will expire five years thereafter. The closing of the offering is expected to occur on or about December 19, 2025, subject to the satisfaction of customary closing...

Continue reading

Purpose Investments Inc. Announces December 2025 Distributions

TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of December 2025 for its open-end exchange traded funds and closed-end funds (“the Funds”). The ex-distribution date for all Open-End Funds is December 29, 2025. The ex-distribution date for all closed-end funds is December 31, 2025.Open-End Funds Ticker Symbol Distribution pershare/unit Record Date Payable Date Distribution FrequencyApple (AAPL) Yield Shares Purpose ETF – ETF Units APLY $0.1667 12/29/2025 01/05/2026 MonthlyPurpose Couche-Tard (ATD) Yield Shares ETF – ETF Series ATDY $0.0650 12/29/2025 01/05/2026 MonthlyPurpose Canadian Financial Income Fund – ETF Series BNC $0.1225¹ 12/29/2025 01/05/2026 MonthlyPurpose Global Bond Fund – ETF Units BND $0.0866 12/29/2025 01/05/2026 MonthlyPurpose...

Continue reading

Next Hydrogen Closes $20.7M Equity Private Placement led by Smoothwater Capital Corporation

MISSISSAUGA, Ontario, Dec. 17, 2025 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (“Next Hydrogen” or the “Company”) is pleased to announce the successful closing of its previously announced non-brokered private placement (the “Offering”) of 46,069,198 common shares of the Company (“Common Shares”) at a price of CAD$0.45 per share (the “Offering Price”), raising gross proceeds of approximately $20.7 million (inclusive of the Shares for Debt Transaction and the Debenture Conversion, as described below). The Offering was led by an affiliate of Toronto based Smoothwater Capital Corporation (“Smoothwater”), which has now become the Company’s largest shareholder holding approximately 47.9% of the issued and outstanding Common Shares, ensuring that Next Hydrogen is Canadian owned and controlled. This financing marks a decisive milestone...

Continue reading

Launchpad Cadenza Acquisition Corp I Announces Pricing of $200,000,000 Initial Public Offering

New York, NY, Dec. 17, 2025 (GLOBE NEWSWIRE) — Launchpad Cadenza Acquisition Corp I (the “Company”) announced today the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Global Stock Market LLC (“Nasdaq”) and begin trading on December 18, 2025, under the ticker symbol “LPCVU.” Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities...

Continue reading

AlphaTON Capital Corp Issues Clarification on Anduril Industries Investment Program

DOVER, DE, Dec. 17, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital Corp (NASDAQ: ATON) (“AlphaTON” or the “Company”), a publicly traded technology company, issues a clarification on its previously announced investment program related to Anduril Industries. Clarification and Correction The Company’s press release on December 16, 2025 regarding an investment in Anduril Industries shares requires clarification. AlphaTON has signed a contract to obtain economic exposure to Anduril Industries’ common stock through a Special Purpose Vehicle (SPV) structure, rather than a direct equity investment in Anduril Industries. It was the company’s intention, clearly outlined in the signed contract, to hold this on its balance sheet. As stated publicly in yesterday’s press release, the intention was also to create a derivative...

Continue reading

Future Mineral Announces Options Grant

TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) — Future Mineral Resources Inc. (formerly Sulliden Mining Capital Inc.) (“Future Mineral” or the “Company”) (TSX: FMR) announced today that, subject to regulatory approval, it has granted 855,000 stock options to certain directors, officers, and consultants of the Company and its affiliates in accordance with the Company’s stock option plan. The options vest immediately and may be exercised at a price of $0.34 per option for a period of four years from the date of grant. The common shares underlying the options are subject to a four-month hold period in accordance with the policies of the Toronto Stock Exchange. About Future Mineral Future Mineral is a mining company focused on acquiring and advancing brownfield, development-stage and early production-stage mining projects in the Americas,...

Continue reading

Vine Hill Capital Investment Corp. II Announces Pricing of Upsized $200 Million Initial Public Offering

Fort Lauderdale, Florida, Dec. 17, 2025 (GLOBE NEWSWIRE) — Vine Hill Capital Investment Corp. II (the “Company”), a special purpose acquisition company, today announced the pricing of its upsized initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to be listed for trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “VHCPU” beginning December 18, 2025. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on Nasdaq under the...

Continue reading

Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement

BERKELEY HEIGHTS, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) — Kalaris Therapeutics, Inc. (NASDAQ: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced that it has entered into a securities purchase agreement with a select group of institutional accredited investors to sell securities in a private placement for aggregate gross proceeds of approximately $50.0 million, before deducting placement agent fees and other offering expenses. The private placement includes participation from both new and existing investors, including ADAR1 Capital Management, Coastlands Capital, Invus, RTW Investments, Samsara BioCapital, Woodline Partners LP and others. In the private placement, pursuant to the terms of the securities purchase...

Continue reading

Repurchased own ordinary shares reached 5% of Tenaris’s voting rights; Tenaris’s controlling shareholder files amendment to Schedule 13D

LUXEMBOURG, Dec. 17, 2025 (GLOBE NEWSWIRE) — Pursuant to applicable Luxembourg Transparency Law requirements, Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris” or the “Company”) announces that on December 17, 2025, the proportion of own ordinary shares acquired under its share buyback program and currently held in treasury has reached 5.07% of Tenaris’s voting rights. Ordinary shares repurchased under such program are being held in treasury (with their voting rights suspended) and will be cancelled in due course. Reporting of share buyback transactions in accordance with Market Abuse Regulation is available at: https://ir.tenaris.com/share-buyback-program. In addition, the Company informs the market that on December 17, 2025, its indirect controlling shareholder San Faustin S.A. and its direct controlling shareholder...

Continue reading

Nukkleus Inc. Receives Shareholder Approval to Acquire Star 26 Capital Inc.

NEW YORK and TEL AVIV, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK) (“Nukkleus” or the “Company”), a strategic acquirer and developer of high-potential businesses in the aerospace and defense (A&D) industry, today announced that its stockholders have approved the acquisition of Star 26 Capital Inc., a defense-focused acquisition company. The transaction is expected to close before December 31, 2025. Pursuant to the approved transaction, Nukkleus is expected to acquire 100% of Star 26 in consideration of a mixed package of cash, equity, and promissory notes, subject to customary adjustments, as well as shares of Nukkleus common stock and associated warrants issued to Star 26 shareholders. Additional details regarding the transaction are available in the Company’s filings with the Securities and Exchange...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.